V CompBrief BY VELARION

Chief Medical Officer · GALECTIN THERAPEUTICS INC (GALT)

Khurram Jamil, M.D.

FY2024 is the first fiscal year CompBrief holds for Khurram Jamil, M.D. as a named executive officer of GALECTIN THERAPEUTICS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$945,847

Compensation figures as of the proxy filed October 22, 2025 (DEF 14A).

Khurram Jamil, M.D. compensation by year

GALECTIN THERAPEUTICS Summary Compensation Table · the one fiscal year held
In US dollars, as GALECTIN THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$365,909
Bonus$120,625
Stock awards$398,500
All other$60,813
Total$945,847

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GALECTIN THERAPEUTICS INC DEF 14A filed October 22, 2025, accession 0001140361-25-038875, and prior-year filings. Open the filing on EDGAR.

GALECTIN THERAPEUTICS’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Joel LewisChief Executive Officer & President$1,189,674
Khurram Jamil, M.D. · this pageChief Medical Officer$945,847
Jack CallicuttChief Financial Officer$716,945

The full GALECTIN THERAPEUTICS compensation record

free company brief
GALECTIN THERAPEUTICS INC (GALT) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within GALECTIN THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order GALECTIN THERAPEUTICS's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosuresFull report & benchmarkingExecutive Compensation Report · $1,500
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are GALECTIN THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy